BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 24, 2006
View Archived Issues
Pharmacopeia Rises On Deal With Cephalon: $15M Up Front
Shares of Pharmacopeia Drug Discovery Inc. jumped 26.3 percent after the company signed a drug discovery deal with Cephalon Inc. that includes a $15 million up-front fee and the potential for double-digit royalties. (BioWorld Today)
Read More
Avanir Buys Alamo, Gains CNS Product, Sales Force
Read More
New River Starts Phase III Study For NRP104 Against Adult ADHD
Read More
BioWorld Releases First Report On Top 25 Biotechnology Drugs
Read More
Hold On Avastin Study Lifted After 60-Day Review By DSMB
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More